πŸ‡ΊπŸ‡Έ FDA
Patent

US 11623932

Protein degraders and uses thereof

granted A61KA61K47/55A61K9/0019

Quick answer

US patent 11623932 (Protein degraders and uses thereof) held by Kymera Therapeutics, Inc. expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Kymera Therapeutics, Inc.
Grant date
Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K47/55, A61K9/0019, A61K9/0053, A61K9/0095